Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

TCON TRACON Pharmaceuticals Inc

1,945

0,055 (2,91%)

Zuletzt aktualisiert: 18:10:45

Verzögert um 15 Minuten

Confidential Treatment Order (ct Order)

This regulatory filing also includes additional resources:
filename1.pdf

TRACON Pharmaceuticals (NASDAQ:TCON)
Historical Stock Chart
Von Mär 2024 bis Apr 2024

Click Here for more TRACON Pharmaceuticals Charts.

TRACON Pharmaceuticals (NASDAQ:TCON)
Historical Stock Chart
Von Apr 2023 bis Apr 2024

Click Here for more TRACON Pharmaceuticals Charts.

News Tracon Pharmaceuticals, Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024
Mittwoch 28 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Freitag 9 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 19 Dezember 2023 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 8 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 20 November 2023 (5 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 9 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 6 Oktober 2023 (7 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 18 September 2023 (7 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Weitere Tracon Pharmaceuticals, Inc. News-Artikel

Deutsche Telekom (QX)

Deutsche Telekom

Euro vs Sterling

BNP Paribas (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen